Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
M. W. P. Carney & P. Rutherford. (1981) Clopenthixol decanoate in schizophrenia. Current Medical Research and Opinion 7:4, pages 205-211.
Read now
Read now
M. W. P. Carney & B. F. Sheffield. (1975) Forty-Two Months Experience of Flupenthixol Decanoate in the Maintenance Treatment of Schizophrenia. Current Medical Research and Opinion 3:7, pages 447-452.
Read now
Read now
Articles from other publishers (16)
A. Gartenmaier, F. Gaese & M. Soyka. 1998. Flupentixol — Typisches oder atypisches Wirkspektrum?. Flupentixol — Typisches oder atypisches Wirkspektrum?
35
65
.
April A. Collins, Gary Remington, Kathryn Coulter & Kirsteen Birkett. (1996) Depression in schizophrenia: a comparison of three measures. Schizophrenia Research 20:1-2, pages 205-209.
Crossref
Crossref
Mala Chintalapudi, Parmanand Kulhara & Ajit Avasthi. (1993) Post-psychotic depression in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 243:2, pages 103-108.
Crossref
Crossref
D.A.W. Johnson. 1993. Antipsychotic Drugs and their Side-Effects. Antipsychotic Drugs and their Side-Effects
205
212
.
Amanda J. Gruber & Jonathan O. Cole. (2012) Antidepressant Effects of Flupenthixol. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 11:6, pages 450-459.
Crossref
Crossref
Parmanand Kulhara, Ajit Avasthi, Rakesh Chadda, Kishore Chandiramani, Surendra K. Mattoo, Suresh K. Kota & Sunny Joseph. (2018) Negative and Depressive Symptoms in Schizophrenia. British Journal of Psychiatry 154:2, pages 207-211.
Crossref
Crossref
Mary M. Robertson & M.R. Trimble. (1982) Major tranquillisers used as antidepressants. Journal of Affective Disorders 4:3, pages 173-193.
Crossref
Crossref
M.E.H. Chowdhury & Carlos Chacon. (1980) Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial. Comprehensive Psychiatry 21:2, pages 135-139.
Crossref
Crossref
Angela Knights, M. S. Okasha, Mohamed Ali Salih & S. R. Hirsch. (2018) Depressive and Extrapyramidal Symptoms and Clinical Effects: A Trial of Fluphenazine versus Flupenthixol in Maintenance of Schizophrenic Out-patients. British Journal of Psychiatry 135:6, pages 515-523.
Crossref
Crossref
A. RANDRUP, I. MUNKVAD, R. FOG, C. BRAESTRUP & L. MOLANDER. 1979. Neuro-Psychopharmacology. Neuro-Psychopharmacology
139
150
.
J. A. Stauning, L. Kirk & A. J�rgensen. (1979) Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo� to schizophrenic patients. Psychopharmacology 65:1, pages 69-72.
Crossref
Crossref
M S Okasha, S R Hirsch, Angela Knights & Mohamed Ali Salih. (1978) Flupenthixol and Fluphenazine Decanoate: A Comparative Review. Psychiatric Annals 8:7, pages 51-67.
Crossref
Crossref
D. A. W. Johnson. (2018) The Expectation of Outcome from Maintenance Therapy in Chronic Schizophrenic Patients. British Journal of Psychiatry 128:3, pages 246-250.
Crossref
Crossref
David C. Watt. (2009) Time to evaluate long-acting neuroleptics?. Psychological Medicine 5:3, pages 222-226.
Crossref
Crossref
D. A. W. Johnson & N. A. Malik. (2014) A DOUBLE‐BLIND COMPARISON OF FLUPHENAZINE DECANOATE AND FLUPENTHIXOL DECANOATE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA. Acta Psychiatrica Scandinavica 51:4, pages 257-267.
Crossref
Crossref
M. T. Haslam, B. M. Bromham & A. A. Schiff. (2007) A COMPARATIVE TRIAL OF FLUPHENAZINE DECANOATE AND FLUPENTHIXOL DECANOATE. Acta Psychiatrica Scandinavica 51:2, pages 92-100.
Crossref
Crossref